Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02102971 · ClinicalTrials.gov registry record
Observational Study of Biomarker During Liver Surgery
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 41
- Enrollment target
NCT02102971 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 41 participants.
The verdict
NCT02102971 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The investigators would like to study whether Sirtuin 1 (SIRT1) plays a cytoprotective role in liver ischemia/reperfusion, and ultimately to develop therapeutic strategies to improve hepatic function of patients with liver diseases.
Interventions
- PROCEDURE Hepatocellular carcinoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-10 |
| Est. Completion | 2019-06-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02102971
The ClinicalTrials.gov registry entry for NCT02102971 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hepatocellular carcinoma is the first listed.
NCT02102971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02102971 about?
NCT02102971 is a clinical study titled "Observational Study of Biomarker During Liver Surgery". The investigators would like to study whether Sirtuin 1 (SIRT1) plays a cytoprotective role in liver ischemia/reperfusion, and ultimately to develop therapeutic strategies to improve hepatic function of patients with liver diseases.
What is the current status of trial NCT02102971?
This trial is currently terminated. The enrollment target is 41 participants. The study started on 2014-10. Estimated completion is 2019-06-06.
What interventions are being tested in trial NCT02102971?
The interventions under investigation include: Hepatocellular carcinoma (PROCEDURE).
Who is sponsoring clinical trial NCT02102971?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.